Detalhe da pesquisa
1.
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
Cell
; 171(3): 540-556.e25, 2017 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28988769
2.
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
Cell
; 174(4): 1033, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096301
3.
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladder.
Histopathology
; 82(7): 991-1002, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754853
4.
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.
J Pathol
; 256(2): 223-234, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731491
5.
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review.
Cancer Causes Control
; 33(8): 1071-1081, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699798
6.
A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.
Br J Cancer
; 125(1): 85-93, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846523
7.
Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
J Urol
; 206(3): 548-557, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881933
8.
Mutational Landscape and Environmental Effects in Bladder Cancer.
Int J Mol Sci
; 21(17)2020 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842545
9.
SIU-ICUD consultation on bladder cancer: basic science.
World J Urol
; 37(1): 15-29, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547196
10.
The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside.
World J Urol
; 37(10): 2041-2049, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415317
11.
Clinical implications of molecular subtyping in bladder cancer.
Curr Opin Urol
; 29(4): 350-356, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31158107
12.
Predictive biomarkers for drug response in bladder cancer.
Int J Urol
; 26(11): 1044-1053, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31370109
13.
CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer.
Br J Cancer
; 119(8): 961-970, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30327565
14.
Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
J Urol
; 200(1): 68-73, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307680
15.
Effects of thiazolidinedione in patients with active bladder cancer.
BJU Int
; 121(2): 244-251, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28872778
16.
Molecular Subtypes of Bladder Cancer.
Curr Oncol Rep
; 20(10): 77, 2018 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30128829
17.
The integrated stress response and proteotoxicity in cancer therapy.
Biochem Biophys Res Commun
; 482(3): 450-453, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212730
18.
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
BJU Int
; 119(5): 684-691, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753185
19.
Genetic subtypes of invasive bladder cancer.
Curr Opin Urol
; 25(5): 449-58, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26218634
20.
Targeting Signaling Transduction Pathways in Bladder Cancer.
Curr Oncol Rep
; 17(12): 58, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26472299